drugset / Trial / NCT00269685

Comparison of Vasopressin and Other Pressors in Septic Shock

NCT00269685

Phase 2/3 Completed 20 enrolled University of Sherbrooke
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the classical tactics in the treatment of septic shock (dopamine, noradrenalin and dobutamine) to the use of vasopressin as first choice pressor. Vasopressin seems to be an interesting alternative in the treatment of septic shock. To this date, available studies have showed that it could correct hyperkinetic syndrome and vasoplegia in septic shocks without noticeable side effect. It as been demonstrated that vasopressin improves renal function, as no effect on digestive organs and as no metabolic effect.

Timeline

Start
2000-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide

Indications

No indication recorded.